CHARLOTTE, N.C. , May 6, 2020 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB) today announced its results for the first quarter ended March 31, 2020 ., First Quarter 2020 Highlights, (Unless otherwise stated, all percent changes are based on year-over-year comparisons) Net sales of $739 million ; Net income of $107 million , or $1.01 per diluted share; Adjusted diluted EPS of $1.00 Adjusted EBITDA of $196 million decreased by ~13% year-over-year, but above previously communicated guidance Taking action to bolster our balance sheet to enhance financial flexibility; drew $250…, Outlook, We are withdrawing full-year 2020 outlook given the uncertainty around the duration and economic impact of the pandemic. We intend to reintroduce our full-year outlook as the situation allows. In an effort to help investors better understand our business, we are temporarily introducing a quarterly outlook. Albemarle anticipates that its Q2 2020 performance will be lower year-over-year based on…, Q2 2020 Outlook, Net sales $700 - $775 million Adjusted EBITDA $140 - $190 million, COVID-19 Response, Albemarle's cross-functional Global Response Team meets regularly to assess the situation and take necessary actions to address employee health and safety and operational challenges. We have implemented protocols including restricting travel, work-from-home for non-essential personnel, and shift adjustments, increased hygiene and social distancing for the essential workers at our plants. We…, First Quarter Results, In millions, except per share amounts, Q1 2020, Q1 2019, $ Change, % Change, Net sales $ 738.8 $ 832.1 $ (93.2) (11.2) % Net income attributable to Albemarle Corporation $ 107.2 $ 133.6 $ (26.4) (19.7) % Adjusted EBITDA (a) $ 196.4 $ 225.9 $ (29.5) (13.1) % Diluted earnings per share $ 1.01 $ 1.26 $ (0.25) (19.8) % Non-operating pension and OPEB items (a) (0.02) (0.01) Non-recurring and other unusual items (a) 0.01 (0.02) Adjusted diluted earnings per share (b) $ 1.…, Business Segment Results, Lithium, In millions, Q1 2020, Q1 2019, $ Change, % Change, Net Sales $ 236.8 $ 291.9 $ (55.1) (18.9) % Adjusted EBITDA $ 78.6 $ 115.6 $ (37.0) (32.0) % Lithium net sales of $236.8 million declined $55.1 million driven by lower pricing and volume. Lower contract pricing reflects 2020 price adjustments that were agreed to in late 2019. As expected, customers reduced Q1 2020 volumes as they worked off excess inventory purchased in Q4 2019. Adjusted EBITDA…, Current Trends:, Our lithium plants in Chengdu and Xinyu operated at reduced rates in early 2020 due to operating restrictions related to COVID-19. Those facilities are now operating at plan. To date, we have experienced minimal order reductions. However, customer closures and order cancellations are likely to affect specialty and technical grade products in Q2 2020. We continue to see solid battery grade…, Bromine Specialties, In millions, Q1 2020, Q1 2019, $ Change, % Change, Net Sales $ 231.6 $ 249.1 $ (17.5) (7.0) % Adjusted EBITDA $ 83.3 $ 78.6 $ 4.7 5.9 % Bromine net sales of $231.6 million declined $17.5 million . Lower volumes due to logistics challenges were partially offset by higher average selling prices. Adjusted EBITDA of $83.3 million was up slightly as cost savings initiatives and reduced minority interest expense offset lower net sales. , Current Trends:, To date, Bromine demand has remained relatively strong; however, future demand is likely to be impacted by recent COVID-19 shut-downs. Due to our position in the supply chain most of the impact is expected to be delayed into H2 2020, and to rebound relatively quickly when economic activity returns to more normal levels. , Catalysts, In millions, Q1 2020, Q1 2019, $ Change, % Change, Net Sales $ 207.2 $ 251.6 $ (44.4) (17.7) % Adjusted EBITDA $ 47.5 $ 60.1 $ (12.6) (21.0) % Catalysts net sales of $207.2 million declined $44.4 million due primarily to lower volumes. Fluid Catalytic Cracking (FCC) volume was down primarily from lower transportation fuel consumption as a result of stay-at-home orders and travel restrictions. Logistics challenges also impacted catalysts volumes…, Current Trends:, Reduced transportation fuel consumption is expected to worsen into Q2 2020, putting further downward pressure on FCC volumes. To date, the Clean Fuel Technology (Hydroprocessing Catalysts or HPC) business has been relatively unaffected; however, based on previous economic downturns, we would expect HPC to be negatively impacted in H2 2020 as refiners defer spending into 2021., All Other, In millions, Q1 2020, Q1 2019, $ Change, % Change, Net Sales $ 63.2 $ 39.5 $ 23.8 60.2 % Adjusted EBITDA $ 22.8 $ 7.2 $ 15.6 215.1 % Other operations represents our Fine Chemistry Services (FCS) business. FCS net sales of $63.2 million increased $23.8 million and adjusted EBITDA of $22.8 million increased $15.6 million . The FCS business tends to be contract driven. Recent contracts include life sciences products which are typically anti-…, Balance Sheet and Liquidity, As of March 31, 2020 , Albemarle had estimated liquidity of $1.7 billion including $553 million of cash and equivalents, $715 million remaining under our $1 billion revolver, $200 million available under our delayed draw term loan, and $190 million on other available credit lines. Total debt was $3.1 billion , representing net debt to adjusted EBITDA of approximately 2.7x. Current leverage is…, Cash Flow and Capital Deployment, First quarter cash from operations of $155.1 million increased $100.1 million versus the prior year as working capital reductions more than offset lower earnings. Capital expenditures of $214.5 million were in-line with the prior year as progress continued on our Lithium expansion projects. We have evaluated our capital allocation priorities under a variety of economic scenarios. Our immediate…, Earnings Call, Date: Thursday, May 7, 2020 Time: 9:00 AM Eastern time Dial-in ( U.S. ): 844-347-1034 Dial-in (International): 209-905-5910 Passcode: 2377882 The Company's earnings presentation and supporting material are available on Albemarle's website at https://investors.albemarle.com ., About Albemarle, Albemarle Corporation (NYSE: ALB), headquartered in Charlotte, N.C. , is a global specialty chemicals company with leading positions in lithium, bromine and refining catalysts. We power the potential of companies in many of the world's largest and most critical industries, from energy and communications to transportation and electronics. Working side-by-side with our customers, we develop value-…, Forward-Looking Statements, Some of the information presented in this press release, the conference call and discussions that follow, including, without limitation, information related to product development, production capacity, committed volumes, market trends, pricing, expected growth, earnings and demand for our products, input costs, surcharges, tax rates, stock repurchases, dividends, cash flow generation, costs and…, Three Months Ended, March 31 ,, 2020, 2019, Net sales, $ 738,845 $ 832,064 Cost of goods sold 496,827 548,578, Gross profit, 242,018 283,486 Selling, general and administrative expenses 101,877 113,355 Research and development expenses 16,097 14,977, Operating profit, 124,044 155,154 Interest and financing expenses (16,885) (12,586) Other income, net 8,314 11,291 Income before income taxes and equity in net income of unconsolidated investments 115,473 153,859 Income tax expense 18,442 37,514 Income before equity in net income of unconsolidated investments 97,031 116,345 Equity in net income of unconsolidated investments (net of tax) 26,604 35,181 Net income…, March 31 ,, December 31 ,, 2020, 2019, ASSETS, Current assets: Cash and cash equivalents $ 553,228 $ 613,110 Trade accounts receivable 518,703 612,651 Other accounts receivable 73,765 67,551 Inventories 853,500 768,984 Other current assets 155,985 162,813 Total current assets 2,155,181 2,225,109 Property, plant and equipment 6,973,817 6,817,843 Less accumulated depreciation and amortization 1,947,848 1,908,370 Net property, plant and…, LIABILITIES AND EQUITY, Current liabilities: Accounts payable $ 573,075 $ 574,138 Accrued expenses 491,579 553,160 Current portion of long-term debt 35,615 187,336 Dividends payable 40,715 38,764 Current operating lease liability 23,826 23,137 Income taxes payable 28,116 32,461 Total current liabilities 1,192,926 1,408,996 Long-term debt 3,105,225 2,862,921 Postretirement benefits 50,673 50,899 Pension benefits 285,851…, Three Months Ended, March 31 ,, 2020, 2019, Cash and cash equivalents at beginning of year $ 613,110 $ 555,320 Cash flows from operating activities: Net income 123,635 151,526 Adjustments to reconcile net income to cash flows from operating activities: Depreciation and amortization 53,694 49,283 Gain on sale of property — (11,079) Stock-based compensation and other 2,501 5,556 Equity in net income of unconsolidated investments (net of tax…, Three Months Ended, March 31 ,, 2020, 2019, Net sales:, Lithium $ 236,818 $ 291,886 Bromine Specialties 231,592 249,052 Catalysts 207,207 251,648 All Other 63,228 39,478 Total net sales $ 738,845 $ 832,064, Adjusted EBITDA:, Lithium $ 78,637 $ 115,616 Bromine Specialties 83,262 78,597 Catalysts 47,470 60,071 All Other 22,824 7,243 Corporate (35,828) (35,660) Total adjusted EBITDA $ 196,365 $ 225,867 See accompanying non-GAAP reconciliations below., Additional Information, It should be noted that adjusted net income attributable to Albemarle Corporation , adjusted diluted earnings per share, non-operating pension and OPEB items per diluted share, non-recurring and other unusual items per diluted share, adjusted effective income tax rates, EBITDA, adjusted EBITDA, EBITDA margin and adjusted EBITDA margin are financial measures that are not required by, or presented…, ALBEMARLE CORPORATION AND SUBSIDIARIES, Non-GAAP Reconciliations, (Unaudited), See below for a reconciliation of adjusted net income attributable to Albemarle Corporation , EBITDA and adjusted EBITDA, the non-GAAP financial measures, to Net income attributable to Albemarle Corporation ("earnings"), the most directly comparable financial measure calculated and reported in accordance with GAAP. Adjusted earnings is defined as earnings before the non-recurring, other unusual…, Three Months Ended, March 31 ,, In thousands, except percentages and per share amounts, 2020, 2019, Net income attributable to Albemarle Corporation $ 107,204 $ 133,569 Add back: Non-operating pension and OPEB items (net of tax) (2,311) (569) Non-recurring and other unusual items (net of tax) 1,493 (2,012) Adjusted net income attributable to Albemarle Corporation $ 106,386 $ 130,988 Adjusted diluted earnings per share $ 1.00 $ 1.23 Weighted-average common shares outstanding – diluted 106,512…, EBITDA, 196,225 232,952 Non-operating pension and OPEB items (2,908) (583) Non-recurring and other unusual items 3,048 (6,502), Adjusted EBITDA, $ 196,365 $ 225,867 Net sales $ 738,845 $ 832,064 EBITDA margin 26.6 % 28.0 % Adjusted EBITDA margin 26.6 % 27.1 % See below for a reconciliation of adjusted EBITDA on a segment basis, the non-GAAP financial measure, to Net income attributable to Albemarle Corporation , the most directly comparable financial measure calculated and reported in accordance with GAAP (in thousands, except percentages…, Lithium, Bromine Specialties, Catalysts, Reportable Segments Total, All Other, Corporate, Consolidated Total, % of Net Sales, Three months ended March 31, 2020 :, Net income (loss) attributable to Albemarle Corporation $ 53,240 $ 71,665 $ 34,892 $ 159,797 $ 20,846 $ (73,439) $ 107,204 14.5 % Depreciation and amortization 25,397 11,597 12,578 49,572 1,978 2,144 53,694 7.3 % Non-recurring and other unusual items — — — — — 3,048 3,048 0.4 % Interest and financing expenses — — — — — 16,885 16,885 2.3 % Income tax expense — — — — — 18,442 18,442 2.5 % Non-…, Adjusted EBITDA, $ 78,637 $ 83,262 $ 47,470 $ 209,369 $ 22,824 $ (35,828) $ 196,365 26.6 %, Three months ended March 31, 2019 :, Net income (loss) attributable to Albemarle Corporation $ 93,169 $ 67,480 $ 47,859 $ 208,508 $ 5,206 $ (80,145) $ 133,569 16.1 % Depreciation and amortization 22,092 11,117 12,212 45,421 2,037 1,825 49,283 5.9 % Non-recurring and other unusual items 355 — — 355 — (6,857) (6,502) (0.8) % Interest and financing expenses — — — — — 12,586 12,586 1.5 % Income tax expense — — — — — 37,514 37,514 4.5 %…, Adjusted EBITDA, $ 115,616 $ 78,597 $ 60,071 $ 254,284 $ 7,243 $ (35,660) $ 225,867 27.1 % Non-operating pension and OPEB items, consisting of mark-to-market actuarial gains/losses, settlements/curtailments, interest cost and expected return on assets, are not allocated to our operating segments and are included in the Corporate category. In addition, we believe that these components of pension cost are mainly…, Three Months Ended, March 31 ,, 2020, 2019, Interest cost $ 7,155 $ 8,869 Expected return on assets (10,063) (9,452) Total $ (2,908) $ (583) In addition to the non-operating pension and OPEB items disclosed above, we have identified certain other items and excluded them from our adjusted net income calculation for the periods presented. A listing of these items, as well as a detailed description of each follows below (per diluted share):, Three Months Ended, March 31 ,, 2020, 2019, Restructuring and other (1) $ 0.01 $ — Acquisition and integration related costs (2) 0.02 0.04 Gain on sale of property (3) — (0.08) Other (4) (0.01) (0.01) Discrete tax items (5) (0.01) 0.03 Total non-recurring and other unusual items $ 0.01 $ (0.02) (1) Included in Cost of goods sold, Selling, general and administrative expenses and Net income attributable to noncontrolling interest for the…, Income before, income taxes and, equity in net income, of unconsolidated investments, Income tax expense, Effective income tax rate, Three months ended March 31, 2020 :, As reported $ 115,473 $ 18,442 16.0 % Non-recurring, other unusual and non-operating pension and OPEB items 461 958 As adjusted $ 115,934 $ 19,400 16.7 %, Three months ended March 31, 2019 :, As reported $ 153,859 $ 37,514 24.4 % Non-recurring, other unusual and non-operating pension and OPEB items (7,085) (4,504) As adjusted $ 146,774 $ 33,010 22.5 % View original content to download multimedia: http://www.prnewswire.com/news-releases/albemarle-reports-first-quarter-results-301054253.html SOURCE Albemarle Corporation Meredith Bandy, 980.999.5168
종류: Article
CHARLOTTE, N.C. , Feb. 19, 2020 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB) today announced its results for the fourth quarter and full year 2019., Fourth Quarter 2019 Highlights, (Based on year-over-year comparisons) Net sales of $993 million increased ~8%, including an unfavorable currency exchange impact of ~1% Diluted EPS of $0.85 decreased ~30% Adjusted diluted EPS of $1.73 increased ~13% Adjusted EBITDA of $295 million increased ~12%, Full Year 2019 Highlights, (Based on year-over-year comparisons) Net sales of $3.6 billion increased ~6%, including an unfavorable foreign exchange impact of ~1% Diluted EPS of $5.02 decreased ~21% Adjusted diluted EPS of $6.04 increased ~10% Adjusted EBITDA of $1.04 billion increased ~3%, Notable Developments, Completed acquisition of 60% ownership in the Wodgina spodumene mine and formed MARBL Lithium Joint Venture with Mineral Resources Limited on Oct. 31, 2019 . Issued a series of notes totaling ~$1.6 billion to repay 1) $1.0 billion balance of the unsecured credit facility primarily used to fund the Wodgina acquisition, 2) ~$350 million of commercial paper notes and 3) the remaining balance of $175…, Full Year 2020 Outlook, As previously communicated on Oct. 24, 2019 , Albemarle anticipates its 2020 performance to be lower year-over-year based on expected lower results from Lithium and flat-to-slightly lower results from Bromine Specialties, partially offset by flat to slightly higher results from Catalysts., 2020 Outlook, vs Full Year 2019, Net sales $3.48 - $3.53 billion (2)% - (3)% Adjusted EBITDA $880 - $930 million (10)% - (15)% Adjusted EPS (per diluted share) $4.80 - $5.10 (16)% - (21)%, Longer-Term View, During Albemarle's Investor Day on Dec. 12, 2019 , company leaders discussed their view on long-range growth prospects through 2024. The company's four-pillar strategy, revealed in 2017, remains intact with an execution shift to adapt to the current lithium environment. Under this strategy, the company plans to: GROW by investing in lithium and generating strong free cash flow across the…, Fourth Quarter Results, In millions, except per share amounts, Q4 2019, Q4 2018, $ Change, % Change, Net sales $ 992.6 $ 921.7 $ 70.9 7.7 % Net income attributable to Albemarle Corporation $ 90.4 $ 129.6 $ (39.2) (30.2) % Adjusted EBITDA (a) $ 294.7 $ 264.3 $ 30.4 11.5 % Diluted earnings per share $ 0.85 $ 1.21 $ (0.36) (29.8) % Non-operating pension and OPEB items (a) 0.19 0.08 Non-recurring and other unusual items (a) 0.69 0.24 Adjusted diluted earnings per share (b) $ 1.73 $ 1.53 $ 0.20…, Fourth Quarter Business Segment Results, Lithium In millions, Q4 2019, Q4 2018, $ Change, % Change, Net Sales $ 411.1 $ 341.6 $ 69.5 20.3 % Adjusted EBITDA $ 140.1 $ 144.5 $ (4.4) (3.1) % Net sales reflects unfavorable currency exchange of ~2%. Adjusted EBITDA reflects favorable currency exchange of ~2% resulting from a weaker Chilean Peso. Net sales grew because of favorable volume of ~27%, largely in battery-grade lithium hydroxide. Pricing was flat, with unfavorable customer mix impacts of ~…, Q4 2019, Q4 2018, $ Change, % Change, Net Sales $ 243.5 $ 239.1 $ 4.4 1.8 % Adjusted EBITDA $ 79.7 $ 70.2 $ 9.5 13.6 % Net sales and adjusted EBITDA both reflect unfavorable currency exchange of ~1%. Net sales increased due to favorable price impacts and product mix of ~3%. Adjusted EBITDA benefited from price and product mix. For the full year 2019, Bromine Specialties net sales and adjusted EBITDA were up ~9% and ~14%, respectively…, Q4 2019, Q4 2018, $ Change, % Change, Net Sales $ 282.5 $ 304.7 $ (22.2) (7.3) % Adjusted EBITDA $ 76.7 $ 78.8 $ (2.0) (2.6) % Net sales and adjusted EBITDA reflect unfavorable currency exchange of ~1% and ~3%, respectively. Net sales decreased in Clean Fuel Technology, or HPC, and Fluid Catalytic Cracking (FCC) Catalysts due to delays in the start-up of new FCC units, partially offset by favorable price impacts and product mix. For…, Q4 2019, Q4 2018, $ Change, % Change, Net Sales $ 55.4 $ 36.2 $ 19.2 53.1 % Adjusted EBITDA $ 20.7 $ 6.4 $ 14.3 225.3 % Net sales and adjusted EBITDA growth primarily reflects increased sales volume of ~51% and ~123%, respectively, in our FCS business. For the full year 2019, All Other net sales and adjusted EBITDA were up ~30% and ~252%, respectively, year-over-year. Corporate Results In millions, Q4 2019, Q4 2018, $ Change, % Change, Adjusted EBITDA $ (22.6) $ (35.5) $ 13.0 (36.5) % Adjusted EBITDA reflects favorable currency exchange of ~8%. Results reflect lower selling, general and administrative spending for professional services., Income Taxes, The effective income tax rate for the fourth quarter of 2019 was (6.5)% compared to 8.6% in the same period in 2018, largely due to a change in geographic earnings mix and tax discretes. The fourth quarter of 2019 includes a $19.0 million tax benefit for uncertain tax positions primarily related to seeking treaty relief from the competent authority to prevent double taxation. On an adjusted basis…, Cash Flow and Capital Deployment, Cash from operations was $719.4 million for the year ended Dec. 31, 2019, an increase of $173.2 million , or 32%, versus the same period in 2018. The result was primarily due to a reduction in the build-up of inventory in our Lithium and Catalysts businesses, the timing of the collection on certain receivables, higher dividends received from unconsolidated investments and increased cash earnings…, Earnings Call, Date: Thursday, Feb. 20, 2020 Time: 9:00 AM Eastern time Dial-in (U.S.): 844-347-1034 Dial-in (International): 209-905-5910 Passcode: 6039717 The Company's earnings presentation and supporting material is available on Albemarle's website at https://investors.albemarle.com ., About Albemarle, Albemarle Corporation (NYSE: ALB), headquartered in Charlotte, N.C. , is a global specialty chemicals company with leading positions in lithium, bromine and refining catalysts. We power the potential of companies in many of the world's largest and most critical industries, from energy and communications to transportation and electronics. Working side-by-side with our customers, we develop value-…, Forward-Looking Statements, Some of the information presented in this press release, the conference call and discussions that follow, including, without limitation, information related to product development, production capacity, committed volumes, market trends, pricing, expected growth, earnings and demand for our products, input costs, surcharges, tax rates, stock repurchases, dividends, cash flow generation, costs and…, Three Months Ended, Year Ended, December 31,, December 31,, 2019, 2018, 2019, 2018, Net sales, $ 992,564 $ 921,699 $ 3,589,427 $ 3,374,950 Cost of goods sold 654,053 601,315 2,331,649 2,157,694, Gross profit, 338,511 320,384 1,257,778 1,217,256 Selling, general and administrative expenses 185,163 120,916 533,368 446,090 Research and development expenses 14,263 16,384 58,287 70,054 Loss (gain) on sale of business — 8,277 — (210,428), Operating profit, 139,085 174,807 666,123 911,540 Interest and financing expenses (22,400) (12,571) (57,695) (52,405) Other expenses, net (38,388) (32,528) (45,478) (64,434) Income before income taxes and equity in net income of unconsolidated investments 78,297 129,708 562,950 794,701 Income tax (benefit) expense (5,105) 11,196 88,161 144,826 Income before equity in net income of unconsolidated investments 83,402…, December 31,, December 31,, 2019, 2018, ASSETS, Current assets: Cash and cash equivalents $ 613,110 $ 555,320 Trade accounts receivable 612,651 605,712 Other accounts receivable 67,551 52,059 Inventories 768,984 700,540 Other current assets 162,813 84,790 Total current assets 2,225,109 1,998,421 Property, plant and equipment 6,817,843 4,799,063 Less accumulated depreciation and amortization 1,908,370 1,777,979 Net property, plant and…, LIABILITIES AND EQUITY, Current liabilities: Accounts payable $ 574,138 $ 522,516 Accrued expenses 553,160 257,323 Current portion of long-term debt 187,336 307,294 Dividends payable 38,764 35,169 Current operating lease liability 23,137 — Income taxes payable 32,461 60,871 Total current liabilities 1,408,996 1,183,173 Long-term debt 2,862,921 1,397,916 Postretirement benefits 50,899 46,157 Pension benefits…, Year Ended, December 31,, 2019, 2018, Cash and cash equivalents at beginning of year $ 555,320 $ 1,137,303 Cash flows from operating activities: Net income 604,357 739,139 Adjustments to reconcile net income to cash flows from operating activities: Depreciation and amortization 213,484 200,698 Gain on sale of business — (210,428) Gain on sale of property (14,411) — Stock-based compensation and other 19,680 15,228 Equity in net income…, Three Months Ended, Year Ended, December 31,, December 31,, 2019, 2018, 2019, 2018, Net sales:, Lithium $ 411,140 $ 341,648 $ 1,358,170 $ 1,228,171 Bromine Specialties 243,464 239,111 1,004,216 917,880 Catalysts 282,522 304,732 1,061,817 1,101,554 All Other 55,438 36,208 165,224 127,186 Corporate — — — 159 Total net sales $ 992,564 $ 921,699 $ 3,589,427 $ 3,374,950, Adjusted EBITDA:, Lithium $ 140,080 $ 144,513 $ 524,934 $ 530,773 Bromine Specialties 79,714 70,195 328,457 288,116 Catalysts 76,734 78,773 270,624 284,307 All Other 20,697 6,362 49,628 14,091 Corporate (22,562) (35,541) (136,862) (110,623) Total adjusted EBITDA $ 294,663 $ 264,302 $ 1,036,781 $ 1,006,664 See accompanying non-GAAP reconciliations below., Additional Information, It should be noted that adjusted net income attributable to Albemarle Corporation , adjusted diluted earnings per share, non-operating pension and OPEB items per diluted share, non-recurring and other unusual items per diluted share, adjusted effective income tax rates, EBITDA, adjusted EBITDA, EBITDA margin and adjusted EBITDA margin are financial measures that are not required by, or presented…, ALBEMARLE CORPORATION AND SUBSIDIARIES, Non-GAAP Reconciliations, (Unaudited), See below for a reconciliation of adjusted net income attributable to Albemarle Corporation , EBITDA and adjusted EBITDA, the non-GAAP financial measures, to Net income attributable to Albemarle Corporation ("earnings"), the most directly comparable financial measure calculated and reported in accordance with GAAP. Adjusted earnings is defined as earnings before the non-recurring, other unusual…, Three Months Ended, Year Ended, December 31,, December 31,, In thousands, except percentages and per share amounts, 2019, 2018, 2019, 2018, Net income attributable to Albemarle Corporation $ 90,391 $ 129,596 $ 533,228 $ 693,562 Add back: Non-operating pension and OPEB items (net of tax) 20,453 8,829 18,648 3,234 Non-recurring and other unusual items (net of tax) 73,430 25,291 90,669 (96,440) Adjusted net income attributable to Albemarle Corporation $ 184,274 $ 163,716 $ 642,545 $ 600,356 Adjusted diluted earnings per share $ 1.73 $ 1…, EBITDA, 164,452 203,550 892,568 1,091,491 Non-operating pension and OPEB items 28,780 11,881 26,970 5,285 Non-recurring and other unusual items (excluding items associated with interest expense) 101,431 48,871 117,243 (90,112), Adjusted EBITDA, $ 294,663 $ 264,302 $ 1,036,781 $ 1,006,664 Net sales $ 992,564 $ 921,699 $ 3,589,427 $ 3,374,950 EBITDA margin 16.6 % 22.1 % 24.9 % 32.3 % Adjusted EBITDA margin 29.7 % 28.7 % 28.9 % 29.8 % See below for a reconciliation of adjusted EBITDA on a segment basis, the non-GAAP financial measure, to Net income attributable to Albemarle Corporation , the most directly comparable financial measure…, Lithium, Bromine Specialties, Catalysts, Reportable Segments Total, All Other, Corporate, Consolidated Total, % of Net Sales, Three months ended December 31, 2019:, Net income (loss) attributable to Albemarle Corporation $ 29,158 $ 67,625 $ 63,358 $ 160,141 $ 18,559 $ (88,309) $ 90,391 9.1 % Depreciation and amortization 27,755 12,330 12,582 52,667 2,138 1,961 56,766 5.7 % Non-recurring and other unusual items (excluding items associated with interest expense) 83,167 (241) 794 83,720 — 17,711 101,431 10.2 % Interest and financing expenses — — — — — 22,400 22…, Adjusted EBITDA, $ 140,080 $ 79,714 $ 76,734 $ 296,528 $ 20,697 $ (22,562) $ 294,663 29.7 %, Three months ended December 31, 2018:, Net income (loss) attributable to Albemarle Corporation $ 112,273 $ 59,333 $ 58,566 $ 230,172 $ 4,359 $ (104,935) $ 129,596 14.1 % Depreciation and amortization 23,433 10,862 11,930 46,225 2,003 1,959 50,187 5.4 % Non-recurring and other unusual items 8,807 — 8,277 17,084 — 31,787 48,871 5.3 % Interest and financing expenses — — — — — 12,571 12,571 1.4 % Income tax expense — — — — — 11,196 11,196…, Adjusted EBITDA, $ 144,513 $ 70,195 $ 78,773 $ 293,481 $ 6,362 $ (35,541) $ 264,302 28.7 %, Year ended December 31, 2019:, Net income (loss) attributable to Albemarle Corporation $ 341,767 $ 279,945 $ 219,686 $ 841,398 $ 41,188 $ (349,358) $ 533,228 14.9 % Depreciation and amortization 99,424 47,611 50,144 197,179 8,440 7,865 213,484 5.9 % Non-recurring and other unusual items (excluding items associated with interest expense) 83,743 901 794 85,438 — 31,805 117,243 3.3 % Interest and financing expenses — — — — — 57,…, Adjusted EBITDA, $ 524,934 $ 328,457 $ 270,624 $ 1,124,015 $ 49,628 $ (136,862) $ 1,036,781 28.9 %, Year ended December 31, 2018:, Net income (loss) attributable to Albemarle Corporation $ 428,212 $ 246,509 $ 445,604 $ 1,120,325 $ 6,018 $ (432,781) $ 693,562 20.6 % Depreciation and amortization 95,193 41,607 49,131 185,931 8,073 6,694 200,698 5.9 % Non-recurring and other unusual items 7,368 — (210,428) (203,060) — 112,948 (90,112) (2.7) % Interest and financing expenses — — — — — 52,405 52,405 1.5 % Income tax expense…, Adjusted EBITDA, $ 530,773 $ 288,116 $ 284,307 $ 1,103,196 $ 14,091 $ (110,623) $ 1,006,664 29.8 % Non-operating pension and OPEB items, consisting of mark-to-market actuarial gains/losses, settlements/curtailments, interest cost and expected return on assets, are not allocated to our operating segments and are included in the Corporate category. In addition, we believe that these components of pension cost are…, Three Months Ended, Year Ended, December 31,, December 31,, 2019, 2018, 2019, 2018, MTM actuarial loss $ 29,339 $ 14,001 $ 29,339 $ 14,001 Interest cost 8,893 8,480 35,394 34,116 Expected return on assets (9,452) (10,600) (37,763) (42,832) Total $ 28,780 $ 11,881 $ 26,970 $ 5,285 In addition to the non-operating pension and OPEB items disclosed above, we have identified certain other items and excluded them from our adjusted net income calculation for the periods presented. A…, Three Months Ended, Year Ended, December 31,, December 31,, 2019, 2018, 2019, 2018, Restructuring and other (1) $ — $ — $ 0.05 $ 0.03 Acquisition and integration related costs (2) 0.05 0.05 0.15 0.14 Albemarle Foundation contribution (3) — — — 0.11 Gain on sale of business (4) — 0.06 — (1.55) Gain on sale of property (5) (0.02) — (0.10) — Stamp duty (6) 0.61 — 0.61 — Windfield tax settlement (7) 0.16 — 0.16 — Legal accrual (8) — — — 0.21 Environmental accrual (9) — — — 0.11 Loss…, Three Months Ended, Year Ended, December 31,, December 31,, 2019, 2018, 2019, 2018, Acquisition and integration related costs:, Cost of goods sold $ 1.0 $ 0.9 $ 1.0 $ 3.7 Selling, general and administrative expenses 5.3 5.5 19.7 15.7 Total $ 6.3 $ 6.4 $ 20.7 $ 19.4 Total acquisition and integration related costs, after income taxes $ 5.1 $ 5.1 $ 16.1 $ 15.7 Total acquisition and integration related costs, per diluted share $ 0.05 $ 0.05 $ 0.15 $ 0.14 (3) Included in Selling, general and administrative expenses for the…, Income before income taxes and equity in net income of unconsolidated investments, Income tax (benefit) expense, Effective income tax rate, Three months ended December 31, 2019:, As reported $ 78,297 $ (5,105) (6.5) % Non-recurring, other unusual and non-operating pension and OPEB items 117,748 41,157 As adjusted $ 196,045 $ 36,052 18.4 %, Three months ended December 31, 2018:, As reported $ 129,708 $ 11,196 8.6 % Non-recurring, other unusual and non-operating pension and OPEB items 60,752 26,632 As adjusted $ 190,460 $ 37,828 19.9 %, Year ended December 31, 2019:, As reported $ 562,950 $ 88,161 15.7 % Non-recurring, other unusual and non-operating pension and OPEB items 131,750 39,725 As adjusted $ 694,700 $ 127,886 18.4 %, Year ended December 31, 2018:, As reported $ 794,701 $ 144,826 18.2 % Non-recurring, other unusual and non-operating pension and OPEB items (84,827) 8,379 As adjusted $ 709,874 $ 153,205 21.6 % View original content to download multimedia: http://www.prnewswire.com/news-releases/albemarle-corporation-finishes-2019-strong-announces-2020-outlook-301007757.html SOURCE Albemarle Corporation Dave Ryan, 980.299.5641
종류: Article